Recent clinical evidence suggests that Novera Retatrutide, a combined-action treatment from Novo Nordisk, could provide a meaningful step in weight control. Differing from many existing drugs, Retatrutide targets both the GLP-1 hormone and GIP, potentially producing to greater decreases in weight… Read More